| PERIOD ENDING | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | | Total Revenue | 85 | 71 | 98 | 168 | | Cost of Revenue | (128) | 138 | (112) | (2,197) | | | Gross Profit | 213 | (67) | 210 | 2,365 | | | Operating Expenses | | Research Development | 47 | 38 | (468) | 110 | | Selling General and Administrative | 481 | 657 | 2,021 | 3,318 | | Non Recurring |
-
|
-
| 2,499 |
-
| | Others | 34 | 47 | 40 | 48 | | | | Total Operating Expenses |
-
|
-
| 4,093 |
-
| | | | Operating Income or Loss | (350) | (808) | (3,883) | (1,111) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (35) | 513 | 7 | (37) | | Earnings Before Interest And Taxes | (385) | (295) | (3,876) | (1,148) | | Interest Expense | 265 | 84 | 110 | 100 | | Income Before Tax | (651) | (379) | (3,986) | (1,248) | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (651) | (379) | (3,986) | (1,248) | | | Non-recurring Events | | Discontinued Operations | (52) |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (703) | (379) | (3,986) | (1,248) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($703) | ($379) | ($3,986) | ($1,248) |
|
0.20% Nasdaq 
Income Statement
